Human SMYD2/HSKM-B/KMT3C ORF/cDNA clone-Adenovirus plasmid (NM_020197.3)

Cat. No.: pGMAD001327
Size: 10 µg
Concentration: generally 0.5ug/ul, usually not less than 0.3ug/ul
Leading Time: 3-7 working days

Pre-made Human SMYD2/HSKM-B/KMT3C adenoviral expression plasmid for SMYD2 adenovirus packaging, SMYD2 adenovirus.

Our GM-Adenovirus vector is optimized with the GMVC-modified Adeasy adenovirus packaging system. Find more about the GMVC-modified adenovirus packaging system.

pdf Datasheet
pdf MSDS
pdf Terms of Use
Target products collection

Go to SMYD2/HSKM-B products collection>>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

Purchase
Shipping fee: Limited-time free
For payment issues, contact us.


Product Description

Catalog ID pGMAD001327
Gene Name SMYD2
Accession Number NM_020197.3
Gene ID 56950
Species Human
Product Type Adenovirus plasmid (overexpression)
Insert Length 1302 bp
Gene Alias HSKM-B,KMT3C,ZMYND14
Fluorescent Reporter EGFP
Mammalian Cell Selection Null
Fusion Tag 3xflag (C-Terminal)
Promoter EF1
Resistance Kanamycin
ORF Nucleotide Sequence ATGAGGGCCGAGGGCCTCGGCGGCCTGGAGCGCTTCTGCAGCCCGGGCAAAGGCCGGGGGCTGCGGGCTCTGCAGCCCTTCCAGGTGGGGGACTTGCTGTTCTCCTGCCCGGCCTATGCCTACGTGCTCACGGTCAACGAGCGGGGCAACCACTGCGAGTACTGCTTCACCAGGAAAGAAGGATTGTCCAAATGTGGAAGATGCAAGCAGGCATTTTACTGCAATGTGGAGTGTCAGAAAGAAGATTGGCCCATGCACAAGCTGGAATGTTCTCCCATGGTTGTTTTTGGGGAAAACTGGAATCCCTCGGAGACTGTAAGACTAACAGCAAGGATTCTGGCCAAACAGAAAATCCACCCAGAGAGAACACCTTCGGAAAAATTGTTAGCTGTGAAGGAGTTTGAATCACATCTGGATAAGTTAGACAATGAGAAGAAGGATTTGATTCAGAGTGACATAGCTGCTCTCCATCACTTTTACTCCAAGCATCTCGGATTCCCTGACAATGATAGCCTCGTAGTACTCTTTGCACAGGTTAACTGTAATGGCTTCACAATTGAAGATGAAGAACTTTCTCATTTGGGATCAGCGATATTTCCTGATGTTGCATTGATGAATCATAGCTGTTGCCCCAATGTCATTGTGACCTACAAAGGGACCCTGGCAGAAGTCAGAGCTGTACAGGAAATCAAGCCGGGAGAGGAGGTTTTTACCAGCTATATTGATCTCCTGTACCCAACGGAAGATAGAAATGACCGGTTAAGAGATTCTTATTTCTTTACCTGTGAGTGCCAGGAGTGTACCACCAAGGACAAGGATAAGGCCAAGGTGGAAATCCGGAAGCTCAGCGATCCCCCAAAGGCAGAAGCCATCCGAGACATGGTCAGATATGCACGCAACGTCATTGAAGAGTTCCGGAGGGCCAAGCACTATAAATCCCCTAGTGAGCTGCTGGAGATCTGCGAGCTCAGCCAGGAGAAGATGAGCTCTGTGTTTGAGGACAGTAACGTGTACATGTTGCACATGATGTACCAGGCCATGGGTGTCTGCTTGTACATGCAGGACTGGGAAGGAGCCCTGCAATATGGACAGAAAATCATTAAGCCCTACAGTAAGCACTATCCTTTGTACTCCCTCAACGTGGCCTCCATGTGGTTGAAGCTAGGGAGACTCTACATGGGCCTGGAACACAAAGCCGCAGGGGAGAAAGCCCTGAAGAAGGCCATTGCAATCATGGAAGTAGCTCACGGCAAAGATCATCCATATATTTCTGAGATCAAACAGGAAATTGAAAGCCACTGA
ORF Protein Sequence MRAEGLGGLERFCSPGKGRGLRALQPFQVGDLLFSCPAYAYVLTVNERGNHCEYCFTRKEGLSKCGRCKQAFYCNVECQKEDWPMHKLECSPMVVFGENWNPSETVRLTARILAKQKIHPERTPSEKLLAVKEFESHLDKLDNEKKDLIQSDIAALHHFYSKHLGFPDNDSLVVLFAQVNCNGFTIEDEELSHLGSAIFPDVALMNHSCCPNVIVTYKGTLAEVRAVQEIKPGEEVFTSYIDLLYPTEDRNDRLRDSYFFTCECQECTTKDKDKAKVEIRKLSDPPKAEAIRDMVRYARNVIEEFRRAKHYKSPSELLEICELSQEKMSSVFEDSNVYMLHMMYQAMGVCLYMQDWEGALQYGQKIIKPYSKHYPLYSLNVASMWLKLGRLYMGLEHKAAGEKALKKAIAIMEVAHGKDHPYISEIKQEIESH

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    Category Cat No. Products Name
    Target Antibody GM-Tg-g-T15797-Ab Anti-SMYD2 monoclonal antibody
    Target Antigen GM-Tg-g-T15797-Ag SMYD2 protein
    ORF Viral Vector pGMAD001327 Human SMYD2 Adenovirus plasmid
    ORF Viral Vector vGMAD001327 Human SMYD2 Adenovirus particle


    Target information

    Target ID GM-T15797
    Target Name SMYD2
    Gene ID 56950, 226830, 709375, 289372, 101081435, 480026, 615229, 100052774
    Gene Symbol and Synonyms 1110020E07Rik,4930402C15,HSKM-B,KMT3C,SMYD2,ZMYND14
    Uniprot Accession Q9NRG4
    Uniprot Entry Name SMYD2_HUMAN
    Protein Sub-location Introcelluar Protein
    Category Therapeutics Target
    Disease Not Available
    Gene Ensembl ENSG00000143499
    Target Classification Not Available

    SET domain-containing proteins, such as SMYD2, catalyze lysine methylation (Brown et al., 2006 [PubMed 16805913]).[supplied by OMIM, Nov 2008]



    About GMVC

    GDU

    GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.